Khalid Islam - Net Worth and Insider Trading
Khalid Islam Net Worth
The estimated net worth of Khalid Islam is at least $1 Million dollars as of 2024-09-20. Khalid Islam is the Executive Chairman of Gain Therapeutics Inc and owns about 930,784 shares of Gain Therapeutics Inc (GANX) stock worth over $1 Million. Details can be seen in Khalid Islam's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Khalid Islam has not made any transactions after 2024-08-09 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Khalid Islam
Khalid Islam Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Khalid Islam owns 4 companies in total, including Fennec Pharmaceuticals Inc (FENC) , Immunomedics Inc (IMMU) , and Processa Pharmaceuticals Inc (PCSA) among others .
Click here to see the complete history of Khalid Islam’s form 4 insider trades.
Insider Ownership Summary of Khalid Islam
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| FENC | Fennec Pharmaceuticals Inc | 2020-08-13 | director |
| IMMU | Immunomedics Inc | 2020-10-23 | director |
| PCSA | Processa Pharmaceuticals Inc | 2020-11-03 | director |
 | | 2024-08-09 | director |
Khalid Islam Latest Holdings Summary
Khalid Islam currently owns a total of 1 stock. Khalid Islam owns 930,784 shares of Gain Therapeutics Inc (GANX) as of August 9, 2024, with a value of $1 Million.
Latest Holdings of Khalid Islam
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| GANX | Gain Therapeutics Inc | 2024-08-09 | 930,784 | 1.50 | 1,396,176 |
Holding Weightings of Khalid Islam
Khalid Islam Form 4 Trading Tracker
According to the SEC Form 4 filings, Khalid Islam has made a total of 1 transactions in Gain Therapeutics Inc (GANX) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Gain Therapeutics Inc is the acquisition of 50,000 shares on August 9, 2024, which cost Khalid Islam around $50,000.
Insider Trading History of Khalid Islam
- 1
Khalid Islam Trading Performance
GuruFocus tracks the stock performance after each of Khalid Islam's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Khalid Islam is %. GuruFocus also compares Khalid Islam's trading performance to market benchmark return within the same time period. The performance of stocks bought by Khalid Islam within 3 months outperforms times out of transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Khalid Islam's insider trading performs compared to the benchmark.
Performance of Khalid Islam
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 10.56 | | | | | |
| Relative Return to S&P 500(%) | 7.58 | | | | | |
Khalid Islam Ownership Network
Khalid Islam Owned Company Details
What does Fennec Pharmaceuticals Inc do?
Who are the key executives at Fennec Pharmaceuticals Inc?
Khalid Islam is the director of Fennec Pharmaceuticals Inc. Other key executives at Fennec Pharmaceuticals Inc include director & Chief Executive Officer Rosty Raykov , Chief Financial Officer Robert Andrade , and Chief Commercial Officer Shubh Goel .
Fennec Pharmaceuticals Inc (FENC) Insider Trades Summary
Over the past 18 months, Khalid Islam made no insider transaction in Fennec Pharmaceuticals Inc (FENC). Other recent insider transactions involving Fennec Pharmaceuticals Inc (FENC) include a net sale of 170,022 shares made by Rosty Raykov , a net sale of 17,180 shares made by Chris A Rallis , and a net sale of 82,950 shares made by Robert Andrade .
In summary, during the past 3 months, insiders sold 8,466 shares of Fennec Pharmaceuticals Inc (FENC) in total and bought 0 shares, with a net sale of 8,466 shares. During the past 18 months, 492,373 shares of Fennec Pharmaceuticals Inc (FENC) were sold and 0 shares were bought by its insiders, resulting in a net sale of 492,373 shares.
Fennec Pharmaceuticals Inc (FENC)'s detailed insider trading history can be found in Insider Trading Tracker table.
Fennec Pharmaceuticals Inc Insider Transactions
Khalid Islam Mailing Address
Above is the net worth, insider trading, and ownership report for Khalid Islam. You might contact Khalid Islam via mailing address: C/o Immunomedics, Inc., 300 The American Road, Morris Plains Nj 07950.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
